Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session
$ALLK
$ALLR
$BLBX
$BNGO
Biotechnology: Pharmaceutical Preparations
Health Care
Biotechnology: Pharmaceutical Preparations
Health Care
Gainers
- ContraFect Corporation (NASDAQ:CFRX) shares surged 213% to $2.82.
- Blackboxstocks Inc. (NASDAQ:BLBX) shares jumped 147.5% to $6.55 after the company announced it entered a letter of intent to merge with Evtec.
- Presto Automation Inc. (NASDAQ:PRST) jumped 114% to $3.00. Presto recently promoted Dan Mosher to President and Xavier Casanova to Chief Operating Officer.
- Windtree Therapeutics, Inc. (NASDAQ:WINT) gained 97% to $8.53. Windtree Therapeutics announced issuance of patent from European Patent Office for Dual Mechanism SERCA2a Activator.
- Satsuma Pharmaceuticals, Inc. (NASDAQ:STSA) jumped 94% to $1.28 after the company announced that it entered a definitive agreement to be acquired by Shin Nippon Biomedical Laboratories for $0.91 per share in cash.
- Prometheus Biosciences, Inc. (NASDAQ:RXDX) gained 69.5% to $193.20 after Merck announced it will acquire the company for $200 per share in cash.
- CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) shares gained 62.3% to $3.8150 after CEO John M Climaco reported the purchase of 15,000 shares at an average price of $0.69 per share and Director Jerzy Gumulka reported the purchase of 7,173 shares at an average price of $0.74 per share.
- NextPlay Technologies, Inc. (NASDAQ:NXTP) rose 30.3% to $1.70 after gaining more than 10% on Friday.
- KWESST Micro Systems Inc. (NASDAQ:KWE) gained 28.4% to $3.3504 after gaining more than 17% on Friday.
- Kiromic BioPharma, Inc. (NASDAQ:KRBP) surged 26.8% to $5.91.
- Creative Media & Community Trust Corporation (NASDAQ:CMCT) rose 27% to $5.44. Daniel M. Negari proposed to acquire all of the outstanding shares of the issuer for $8.88 per share in cash in an amended 13D filing.
- Marker Therapeutics, Inc. (NASDAQ:MRKR) gained 20.9% to $1.33.
- Peakstone Realty Trust (NYSE:PKST) gained 20.8% to $21.75.
- Morphic Holding, Inc. (NASDAQ:MORF) jumped 19.5% to $41.38.
- Dragonfly Energy Holdings Corp. (NASDAQ:DFLI) gained 19.4% to $5.12. Dragonfly Energy recently reported worse-than-expected Q4 sales results.
- Biotricity, Inc. (NASDAQ:BTCY) gained 18.8% to $0.6294.
- ImmunityBio, Inc. (NASDAQ:IBRX) surged 18% to $2.28.
- Vapotherm, Inc. (NASDAQ:VAPO) rose 17.3% to $0.61.
- Vaxcyte, Inc. (NASDAQ:PCVX) gained 16.8% to $42.66 after the company reported data from its Phase 2 study of its 24-valent pneumococcal conjugate vaccine candidate.
- Versus Systems Inc. (NASDAQ:VS) gained 15.2% to $0.6750.
- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) rose 15% to $2.7708.
- Seres Therapeutics, Inc. (NASDAQ:MCRB) gained 14.5% to $6.71.
- Revelation Biosciences, Inc. (NASDAQ:REVB) jumped 14.3% to $1.3601. Revelation Biosciences recently posted a Q4 loss of $1.77 per share.
- Editas Medicine, Inc. (NASDAQ:EDIT) rose 13.5% to $8.61.
- Rackspace Technology, Inc. (NASDAQ:RXT) gained 13.5% to $2.0315.
- XPeng Inc. (NYSE:XPEV) shares rose 12.1% to $11.12 after the company launched a new platform which will cut its R&D cycle by 20%.
- Allakos Inc. (NASDAQ:ALLK) jumped 11.8% to $4.2150.
- National CineMedia, Inc. (NASDAQ:NCMI) gained 11% to $0.3864 after declining around 19% on Friday. The company recently filed a voluntary Chapter 11 petition in the U.S. Bankruptcy Court for the Southern District of Texas.
- LivaNova PLC (NASDAQ:LIVN) jumped 8.8% to $46.35. LivaNova said Damien McDonald has resigned as Chief Executive Officer. The company sees Q1 revenue of $263 million.
- RAPT Therapeutics, Inc. (NASDAQ:RAPT) gained 7.5% to $18.02.
Losers
- Marpai, Inc. (NASDAQ:MRAI) shares fell 44.4% to $1.04 after the company priced an underwritten public offering of 7,400,000 shares at $1.00 per share.
- Pear Therapeutics, Inc. (NASDAQ:PEAR) fell 29.6% to $0.0506 after dropping over 39% on Friday. The company recently filed for Chapter 11 and said it will seek to sell its assets through a sales process.
- SAI.TECH Global Corporation (NASDAQ:SAI) dropped 28% to $3.53 after jumping 222% on Friday.
- Near Intelligence, Inc. (NASDAQ:NIR) fell 27.2% to $4.34 after surging 100% on Friday.
- Inpixon (NASDAQ:INPX) dropped 27% to $0.70.
- CXApp Inc. (NASDAQ:CXAI) fell 22.2% to $10.74 after jumping 94% on Friday.
- Bionano Genomics, Inc. (NASDAQ:BNGO) shares fell 21.1% to $0.8601 after dropping 6% on Friday. Bionano announced presentation of OGM utility across cancer genomics research applications at the AACR.
- Oblong, Inc. (NASDAQ:OBLG) fell 20% to $2.1580.
- Predictive Oncology Inc. (NASDAQ:POAI) dropped 18.4% to $0.31.
- Jeffs' Brands Ltd (NASDAQ:JFBR) dipped 17.2% to $1.0350.
- Nogin, Inc. (NASDAQ:NOGN) fell 16.8% to $2.3884.
- Allarity Therapeutics, Inc. (NASDAQ:ALLR) fell 16.6% to $1.20.
- Ideanomics, Inc. (NASDAQ:IDEX) declined 15.4% to $0.0638.
- Laser Photonics Corporation (NASDAQ:LASE) dropped 15.1% to $3.48 after the company posted a loss for its fourth quarter.
- Roblox Corporation (NYSE:RBLX) fell 14% to $39.30 after the company reported key metrics for March.
- Rosecliff Acquisition Corp I (NASDAQ:RCLF) fell 13.1% to $12.18.
- State Street Corporation (NYSE:STT) dropped 12.5% to $70.01 after the company reported worse-than-expected Q1 EPS and sales results.
- SMX (Security Matters) Public Limited Company (NASDAQ:SMX) fell 12.1% to $1.84 after dropping 7% on Friday.
- Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) fell 11.4% to $4.0675 after jumping 306% on Friday.
- Manchester United plc (NYSE:MANU) dropped 11.3% to $19.53.
- Willis Lease Finance Corporation (NASDAQ:WLFC) fell 11% to $51.43.
- Moderna, Inc. (NASDAQ:MRNA) dropped 7.8% to $144.82. Moderna presented data with Merck & Company showing mRNA-4157 in combination with KEYTRUDA reduced the risk of recurrence or death by 44% compared to KEYTRUDA alone in patients with stage III/IV melanoma.
Now Read This: Wall Street's Most Accurate Analysts Say Sell These 3 Tech Stocks Delivering High-Dividend Yields